Cochrane Evidence Synthesis and Methods ►

Ketamine and other NMDA receptor antagonists for chronic pain

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of ketamine and other NDMA receptor antagonists compared to placebo, usual care, or other medicines for adults with chronic non-cancer pain.

This is a protocol.

Published:

23 February 2023

Authors:

Ferraro MC, Cashin AG, O'Connell NE, Visser EJ., Abdel Shaheed C, Wewege MA, Gustin SM, McAuley JH

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Ferraro MC, Cashin AG, O'Connell NE, Visser EJ., Abdel Shaheed C, Wewege MA, Gustin SM, McAuley JH. Ketamine and other NMDA receptor antagonists for chronic pain (Protocol). Cochrane Database of Systematic Reviews 2023, Issue 2. Art. No.: CD015373. DOI: 10.1002/14651858.CD015373.